These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 19033703)

  • 1. [Treatment of gastric cancer].
    Lordick F; Ridwelski K; Al-Batran SE; Trarbach T; Schlag PM; Piso P
    Onkologie; 2008; 31 Suppl 5():32-9. PubMed ID: 19033703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neo-adjuvants, adjuvants and palliative therapy for gastric carcinoma].
    Klein HO
    Praxis (Bern 1994); 1998 Mar; 87(13):451-4. PubMed ID: 9584571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group.
    Van Cutsem E; Van de Velde C; Roth A; Lordick F; Köhne CH; Cascinu S; Aapro M;
    Eur J Cancer; 2008 Jan; 44(2):182-94. PubMed ID: 18093827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of chemotherapy in patients with established gastric cancer.
    Wagner AD; Schneider PM; Fleig WE
    Best Pract Res Clin Gastroenterol; 2006; 20(4):789-99. PubMed ID: 16997160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Patient with stomach cancer with metastases. What is the value of chemotherapy?].
    Wilke H; Stahl M; Vanhoefer U
    MMW Fortschr Med; 2003 Nov; 145(48):39-42. PubMed ID: 14724998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG).
    Leong T; Smithers BM; Michael M; Gebski V; Boussioutas A; Miller D; Simes J; Zalcberg J; Haustermans K; Lordick F; Schuhmacher C; Swallow C; Darling G; Wong R
    BMC Cancer; 2015 Jul; 15():532. PubMed ID: 26194186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combination chemotherapy for gastric cancer including LV/5-FU].
    Sasaki T; Maeda Y; Kandaba-shi K; Ono M
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):1952-6. PubMed ID: 15570919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 7-Year survival results of perioperative chemotherapy with epidoxorubicin, etoposide, and cisplatin (EEP) in locally advanced resectable gastric cancer: up-to-date analysis of a phase-II study.
    Persiani R; Rausei S; Pozzo C; Biondi A; Barone C; Cananzi FC; Schinzari G; D'Ugo D
    Ann Surg Oncol; 2008 Aug; 15(8):2146-52. PubMed ID: 18543037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of gastric cancer.
    Moehler M; Galle PR; Gockel I; Junginger T; Schmidberger H
    Best Pract Res Clin Gastroenterol; 2007; 21(6):965-81. PubMed ID: 18070698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted agents for adjuvant therapy of colon cancer.
    de Gramont A; Tournigand C; André T; Larsen AK; Louvet C
    Semin Oncol; 2006 Dec; 33(6 Suppl 11):S42-5. PubMed ID: 17178286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Issues of adjuvant chemotherapy in gastric cancer: its clinical significance].
    Nakajima T
    Gan To Kagaku Ryoho; 1991 May; 18(6):952-7. PubMed ID: 2029198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adjuvant therapy of colon carcinoma].
    Trarbach T; Kubicka S; Hacker U; Ridwelski K; Reinacher-Schick A
    Onkologie; 2008; 31 Suppl 5():19-23. PubMed ID: 19033700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric cancer.
    Catalano V; Labianca R; Beretta GD; Gatta G; de Braud F; Van Cutsem E
    Crit Rev Oncol Hematol; 2009 Aug; 71(2):127-64. PubMed ID: 19230702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of the paclitaxel, cisplatin, 5-fluorouracil and leucovorin (TPFL) regimen in the treatment of advanced or metastatic gastric cancer.
    Jung JY; Kwon JH; Kim JH; Song HH; Kim I; Lee KS; Kim HJ; Zang DY; Ahn JS; Lee JA; Park YI
    Oncol Rep; 2009 Feb; 21(2):523-9. PubMed ID: 19148531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biweekly oxaliplatin, fluorouracil and leucovorin versus cisplatin, fluorouracil and leucovorin in patients with advanced gastric cancer.
    Popov I; Radosevic-Jelic L; Jezdic S; Milovic M; Borojevic N; Stojanovic S; Stankovic V; Josifovski T; Kezic I
    J BUON; 2008; 13(4):505-11. PubMed ID: 19145671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of self-expandable metallic stent plus chemotherapy for metastatic gastric cancer with pyloric stenosis.
    Shimura T; Kataoka H; Sasaki M; Yamada T; Hayashi K; Togawa S; Okumura F; Kubota E; Ohara H; Joh T
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1358-64. PubMed ID: 19467141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant therapy in gastric and cardia cancer: should we irradiate?
    Van Laethem JL; Demols A
    Curr Opin Oncol; 2006 Jul; 18(4):381-5. PubMed ID: 16721135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-center phase II trial of weekly paclitaxel plus cisplatin combination chemotherapy in patients with advanced gastric and gastro-esophageal cancer.
    Sun Q; Liu C; Zhong H; Zhong B; Xu H; Shen W; Wang D
    Jpn J Clin Oncol; 2009 Apr; 39(4):237-43. PubMed ID: 19264768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolving chemotherapy for advanced gastric cancer.
    Ajani JA
    Oncologist; 2005; 10 Suppl 3():49-58. PubMed ID: 16368871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.